US Stock MarketDetailed Quotes

PHIO Phio Pharmaceuticals

Watchlist
  • 1.7600
  • +0.0200+1.15%
Close Dec 20 16:00 ET
  • 1.6601
  • -0.0999-5.68%
Post 19:57 ET
2.63MMarket Cap-0.18P/E (TTM)

Phio Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-35.89%5.39M
-58.45%4.7M
-28.33%6.48M
-27.93%8.49M
-27.93%8.49M
-41.96%8.41M
-37.25%11.31M
-55.84%9.04M
-51.03%11.78M
-51.03%11.78M
-Cash and cash equivalents
-35.89%5.39M
-58.45%4.7M
-28.33%6.48M
-27.93%8.49M
-27.93%8.49M
-41.96%8.41M
-37.25%11.31M
-55.84%9.04M
-51.03%11.78M
-51.03%11.78M
Restricted cash
----
----
----
--0
--0
0.00%50K
0.00%50K
0.00%50K
0.00%50K
0.00%50K
Other current assets
-45.58%474K
-12.39%594K
16.93%373K
35.28%832K
35.28%832K
3.32%871K
-58.10%678K
-72.45%319K
-0.81%615K
-0.81%615K
Total current assets
-37.14%5.86M
-56.03%5.29M
-27.18%6.85M
-25.10%9.32M
-25.10%9.32M
-39.34%9.33M
-38.87%12.04M
-56.60%9.4M
-49.67%12.45M
-49.67%12.45M
Non current assets
Net PPE
-99.52%1K
-99.61%1K
-99.33%2K
-88.66%39K
-88.66%39K
-46.67%208K
-40.56%255K
-36.54%297K
-17.31%344K
-17.31%344K
-Gross PPE
-99.52%1K
-99.61%1K
-99.33%2K
-22.65%1.18M
-22.65%1.18M
-46.67%208K
-40.56%255K
-36.54%297K
-0.13%1.52M
-0.13%1.52M
-Accumulated depreciation
----
----
----
3.32%-1.14M
3.32%-1.14M
----
----
----
-6.33%-1.18M
-6.33%-1.18M
Other non current assets
----
-50.00%3K
-50.00%3K
-87.50%3K
-87.50%3K
-87.50%3K
-77.78%6K
-77.78%6K
-11.11%24K
-11.11%24K
Total non current assets
-99.53%1K
-98.47%4K
-98.35%5K
-88.59%42K
-88.59%42K
-49.03%211K
-42.76%261K
-38.79%303K
-16.93%368K
-16.93%368K
Total assets
-38.52%5.87M
-56.93%5.3M
-29.40%6.85M
-26.92%9.36M
-26.92%9.36M
-39.59%9.54M
-38.96%12.3M
-56.20%9.71M
-49.09%12.81M
-49.09%12.81M
Liabilities
Current liabilities
Payables
6.36%184K
-47.74%335K
-64.52%320K
-15.66%657K
-15.66%657K
-68.14%173K
-44.16%641K
174.16%902K
175.27%779K
175.27%779K
-accounts payable
6.36%184K
-47.74%335K
-64.52%320K
-15.66%657K
-15.66%657K
-68.14%173K
-44.16%641K
174.16%902K
175.27%779K
175.27%779K
Current accrued expenses
-64.71%735K
-27.87%1.19M
-31.49%929K
16.69%720K
16.69%720K
37.13%2.08M
-6.37%1.65M
-35.95%1.36M
-70.45%617K
-70.45%617K
Current debt and capital lease obligation
----
----
----
-74.07%35K
-74.07%35K
-46.97%70K
-20.00%104K
8.66%138K
8.00%135K
8.00%135K
-Current capital lease obligation
--0
--0
--0
-74.07%35K
-74.07%35K
-46.97%70K
-20.00%104K
8.66%138K
8.00%135K
8.00%135K
Current liabilities
-60.49%919K
-36.33%1.52M
-47.87%1.25M
-15.73%1.63M
-15.73%1.63M
6.02%2.33M
-21.24%2.39M
-6.88%2.4M
-36.80%1.94M
-36.80%1.94M
Non current liabilities
Long term debt and capital lease obligation
----
----
----
--0
--0
--0
--0
--0
-79.41%35K
-79.41%35K
-Long term capital lease obligation
----
----
----
--0
--0
--0
--0
--0
-79.41%35K
-79.41%35K
Preferred securities outside stock equity
----
----
----
--0
--0
--0
--0
--0
--2K
--2K
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
-78.24%37K
-78.24%37K
Total liabilities
-60.49%919K
-36.33%1.52M
-47.87%1.25M
-17.31%1.63M
-17.31%1.63M
2.74%2.33M
-23.85%2.39M
-11.62%2.4M
-38.97%1.98M
-38.97%1.98M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
----
----
----
----
--0
----
----
Retained earnings
-5.40%-144.73M
-6.45%-143.21M
-7.11%-141.36M
-8.43%-139.21M
-8.43%-139.21M
-9.28%-137.31M
-10.21%-134.53M
-10.41%-131.98M
-9.82%-128.38M
-9.82%-128.38M
Paid-in capital
3.56%149.68M
1.76%146.98M
5.51%146.96M
5.54%146.94M
5.54%146.94M
3.84%144.52M
3.85%144.44M
0.22%139.29M
0.28%139.22M
0.28%139.22M
Total stockholders'equity
-31.43%4.95M
-61.90%3.77M
-23.35%5.6M
-28.68%7.73M
-28.68%7.73M
-46.68%7.21M
-41.75%9.9M
-62.41%7.31M
-50.58%10.84M
-50.58%10.84M
Total equity
-31.43%4.95M
-61.90%3.77M
-23.35%5.6M
-28.68%7.73M
-28.68%7.73M
-46.68%7.21M
-41.75%9.9M
-62.41%7.31M
-50.58%10.84M
-50.58%10.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -35.89%5.39M-58.45%4.7M-28.33%6.48M-27.93%8.49M-27.93%8.49M-41.96%8.41M-37.25%11.31M-55.84%9.04M-51.03%11.78M-51.03%11.78M
-Cash and cash equivalents -35.89%5.39M-58.45%4.7M-28.33%6.48M-27.93%8.49M-27.93%8.49M-41.96%8.41M-37.25%11.31M-55.84%9.04M-51.03%11.78M-51.03%11.78M
Restricted cash --------------0--00.00%50K0.00%50K0.00%50K0.00%50K0.00%50K
Other current assets -45.58%474K-12.39%594K16.93%373K35.28%832K35.28%832K3.32%871K-58.10%678K-72.45%319K-0.81%615K-0.81%615K
Total current assets -37.14%5.86M-56.03%5.29M-27.18%6.85M-25.10%9.32M-25.10%9.32M-39.34%9.33M-38.87%12.04M-56.60%9.4M-49.67%12.45M-49.67%12.45M
Non current assets
Net PPE -99.52%1K-99.61%1K-99.33%2K-88.66%39K-88.66%39K-46.67%208K-40.56%255K-36.54%297K-17.31%344K-17.31%344K
-Gross PPE -99.52%1K-99.61%1K-99.33%2K-22.65%1.18M-22.65%1.18M-46.67%208K-40.56%255K-36.54%297K-0.13%1.52M-0.13%1.52M
-Accumulated depreciation ------------3.32%-1.14M3.32%-1.14M-------------6.33%-1.18M-6.33%-1.18M
Other non current assets -----50.00%3K-50.00%3K-87.50%3K-87.50%3K-87.50%3K-77.78%6K-77.78%6K-11.11%24K-11.11%24K
Total non current assets -99.53%1K-98.47%4K-98.35%5K-88.59%42K-88.59%42K-49.03%211K-42.76%261K-38.79%303K-16.93%368K-16.93%368K
Total assets -38.52%5.87M-56.93%5.3M-29.40%6.85M-26.92%9.36M-26.92%9.36M-39.59%9.54M-38.96%12.3M-56.20%9.71M-49.09%12.81M-49.09%12.81M
Liabilities
Current liabilities
Payables 6.36%184K-47.74%335K-64.52%320K-15.66%657K-15.66%657K-68.14%173K-44.16%641K174.16%902K175.27%779K175.27%779K
-accounts payable 6.36%184K-47.74%335K-64.52%320K-15.66%657K-15.66%657K-68.14%173K-44.16%641K174.16%902K175.27%779K175.27%779K
Current accrued expenses -64.71%735K-27.87%1.19M-31.49%929K16.69%720K16.69%720K37.13%2.08M-6.37%1.65M-35.95%1.36M-70.45%617K-70.45%617K
Current debt and capital lease obligation -------------74.07%35K-74.07%35K-46.97%70K-20.00%104K8.66%138K8.00%135K8.00%135K
-Current capital lease obligation --0--0--0-74.07%35K-74.07%35K-46.97%70K-20.00%104K8.66%138K8.00%135K8.00%135K
Current liabilities -60.49%919K-36.33%1.52M-47.87%1.25M-15.73%1.63M-15.73%1.63M6.02%2.33M-21.24%2.39M-6.88%2.4M-36.80%1.94M-36.80%1.94M
Non current liabilities
Long term debt and capital lease obligation --------------0--0--0--0--0-79.41%35K-79.41%35K
-Long term capital lease obligation --------------0--0--0--0--0-79.41%35K-79.41%35K
Preferred securities outside stock equity --------------0--0--0--0--0--2K--2K
Total non current liabilities --0--0--0--0--0--0--0--0-78.24%37K-78.24%37K
Total liabilities -60.49%919K-36.33%1.52M-47.87%1.25M-17.31%1.63M-17.31%1.63M2.74%2.33M-23.85%2.39M-11.62%2.4M-38.97%1.98M-38.97%1.98M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0------------------0--------
Retained earnings -5.40%-144.73M-6.45%-143.21M-7.11%-141.36M-8.43%-139.21M-8.43%-139.21M-9.28%-137.31M-10.21%-134.53M-10.41%-131.98M-9.82%-128.38M-9.82%-128.38M
Paid-in capital 3.56%149.68M1.76%146.98M5.51%146.96M5.54%146.94M5.54%146.94M3.84%144.52M3.85%144.44M0.22%139.29M0.28%139.22M0.28%139.22M
Total stockholders'equity -31.43%4.95M-61.90%3.77M-23.35%5.6M-28.68%7.73M-28.68%7.73M-46.68%7.21M-41.75%9.9M-62.41%7.31M-50.58%10.84M-50.58%10.84M
Total equity -31.43%4.95M-61.90%3.77M-23.35%5.6M-28.68%7.73M-28.68%7.73M-46.68%7.21M-41.75%9.9M-62.41%7.31M-50.58%10.84M-50.58%10.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.